Ketorolac Tromethamine en es it fr

Ketorolac Tromethamine Brand names, Ketorolac Tromethamine Analogs

Ketorolac Tromethamine Brand Names Mixture

  • No information avaliable

Ketorolac Tromethamine Chemical_Formula

C17H11N5

Ketorolac Tromethamine RX_link

http://www.rxlist.com/cgi/generic2/letroz.htm

Ketorolac Tromethamine fda sheet

Ketorolac_Tromethamine FDA

Ketorolac Tromethamine msds (material safety sheet)

Ketorolac Tromethamine Synthesis Reference

No information avaliable

Ketorolac Tromethamine Molecular Weight

285.303 g/mol

Ketorolac Tromethamine Melting Point

184-185 oC

Ketorolac Tromethamine H2O Solubility

No information avaliable

Ketorolac Tromethamine State

Solid

Ketorolac Tromethamine LogP

3.385

Ketorolac Tromethamine Dosage Forms

Tablet

Ketorolac Tromethamine Indication

For the extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy. Also for first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Ketorolac Tromethamine Pharmacology

Letrozole is an aromatase inhibitor used in the treatment of breast cancer. Aromatase inhibitors work by inhibiting the action of the enzyme aromatase, which converts androgens into estrogens by a process called aromatization. As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue.

Ketorolac Tromethamine Absorption

Rapidly and completely absorbed. Absorption is not affected by food.

Ketorolac Tromethamine side effects and Toxicity

No information avaliable

Ketorolac Tromethamine Patient Information

No information avaliable

Ketorolac Tromethamine Organisms Affected

Humans and other mammals